High flow oxygen compared to standard flow oxygen for hospitalized adults with acute hypoxemia in Africa (BREATHE): a protocol for a multinational Type 1 implementation-effectiveness randomized controlled trial
Wellcome Open Research · 12.11.2026 · 11 · 981
DOI: 10.12688/wellcomeopenres.27668.1 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Wellcome Open Research, online erschienen am 12.11.2026. Verfasst von Elisabeth Riviello und 39 weiteren Autor:innen. Die Arbeit nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Harvard Global Health Institute.
Abstract (Originalsprache)
Acute hypoxemic respiratory failure is common and associated with high mortality, particularly in resource-constrained settings. High flow oxygen is a form of advanced non-invasive respiratory support that has been demonstrated to reduce the need for invasive mechanical ventilation (moderate certainty) and reduce mortality (low certainty) in adults with acute hypoxemic respiratory failure in resource-rich settings. High flow oxygen has the potential to provide even greater benefit in resource-constrained settings where safe mechanical ventilation is less available, though also has the potential for increased risk in these settings. BREATHE is a multinational Type 1 implementation-effectiveness randomized controlled trial, with a primary objective to determine whether protocolized high flow oxygen will change in-hospital mortality as compared with protocolized standard flow oxygen. We will complete a randomized controlled trial of 1600 adults with acute hypoxemia in five hospitals in Kenya, Malawi, and Rwanda with two arms: protocolized high flow oxygen and protocolized standard flow oxygen. Adults admitted to these hospitals are screened within 24 hours of admission. Patients who are eligible and consent are randomized to either high flow or standard flow oxygen throughout their hospitalizations. All participants receive protocolized oxygen therapy: monitoring with pulse oximetry at prescribed intervals, titration to peripheral oxygen saturation range of 90–94%, and liberation from oxygen therapy per a de-escalation protocol. Qualitative data from research staff, clinical staff, and patients and families is collected and analyzed, to assess contextual factors influencing implementation. The primary outcome is in-hospital mortality. Secondary outcomes include 90-day mortality; 90-day functional status; 90-day readmission; hospital care outcomes; escalation to ventilation; oxygen consumption; and implementation factors. We will also compare outcomes for trial participants with outcomes for participants in a baseline audit who received usual oxygen therapy at these hospitals prior to the trial. ,
Förderung
- Wellcome Trust
- Harvard Global Health Institute
Zitieren
APA
Riviello, E., Angelo, S., Vanderberg, S., Herbst, A., Adam, M., Babu, V., Banda, P., Beane, A., Brotherton, J., Calhoun, T., Condo, J., Dula, D., Ely, E. W., Gahungu, B., Gashame, D. F., Goel, S., Gordon, S., Haniffa, R., Hedt-Gauthier, B., …, & Uwamahoro, D. (2026). High flow oxygen compared to standard flow oxygen for hospitalized adults with acute hypoxemia in Africa (BREATHE): a protocol for a multinational Type 1 implementation-effectiveness randomized controlled trial. Wellcome Open Research, 11, 981. https://doi.org/10.12688/wellcomeopenres.27668.1
Vancouver
Riviello E, Angelo S, Vanderberg S, Herbst A, Adam M, Babu V, et al. High flow oxygen compared to standard flow oxygen for hospitalized adults with acute hypoxemia in Africa (BREATHE): a protocol for a multinational Type 1 implementation-effectiveness randomized controlled trial. Wellcome Open Research. 2026;11:981. doi:10.12688/wellcomeopenres.27668.1
BibTeX
@article{Riviello2026,
author = {Riviello, Elisabeth and Angelo, Sahil and Vanderberg, Sky and Herbst, Austin and Adam, Mary and Babu, Varshini and Banda, Peter and Beane, Abi and Brotherton, Jason and Calhoun, Tiara and Condo, Jeanine and Dula, Dingase and Ely, E. Wes and Gahungu, Blaise and Gashame, Dona Fabiola and Goel, Swati and Gordon, Stephen and Haniffa, Rashan and Hedt-Gauthier, Bethany and Kageche, Wanja and Karmali, Dipan and Kebeney, Nelly and Limbani, Felix and Lipnick, Michael and Mathur, Pooja and Njoki, Carolyne and Oduor, Peter and Onofrey, Lauren and Otieno, George and Pisani, Luigi and Raddawi, Mary and Rudd, Kristina and Rylance, Jamie and Savarimuthu, Stella and Shrime, Mark and Spencer, Stephen and Sulani, Innocent and Trevisi, Letizia and Umutoni, Nathalie and Uwamahoro, Doris},
title = {High flow oxygen compared to standard flow oxygen for hospitalized adults with acute hypoxemia in Africa (BREATHE): a protocol for a multinational Type 1 implementation-effectiveness randomized controlled trial},
journal = {Wellcome Open Research},
year = {2026},
volume = {11},
pages = {981},
doi = {10.12688/wellcomeopenres.27668.1}
}
EUVIMED